Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Letrozole -Berberine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Polycystic Ovary Syndrome
1 trial -
Leuprorelin acetate + Sintilimab
The First People's Hospital of Lianyungang
NSCLC, Stage III
1 trial -
Levetiracetam (Keppra)
United Therapeutics Europe Ltd
Alcohol Abuse
1 trial -
Levofloxacin
The First People's Hospital of Lianyungang
Acute Ischemic Stroke
3 trials -
Lidocaine
The First People's Hospital of Lianyungang
Heart Failure
1 trial -
Lidocaine Hydrochloride, Injectable
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Primary Liver Cancer
1 trial -
Lipid-based nutrient supplement
United Therapeutics Europe Ltd
Malnutrition
1 trial -
Liquid Biopsy Early Screening
The First People's Hospital of Lianyungang
Liquid Biopsy for Early Screening of Lung Cancer
1 trial -
Liraglutide
The First People's Hospital of Lianyungang
Ischemic Stroke
1 trial -
Low potassium content vegetables
Xiyuan Hospital of China Academy of Chinese Medical Sciences
End-stage Renal Disease
1 trial -
Low strength nicotine e-liquid
BRIGHT MINDS BIOSCIENCES INC.
Electronic Cigarette Use
1 trial -
Lubiprostone
Takeda
Constipation-predominant Irritable Bowel Syndrome
1 trial -
Luspatercept
The First People's Hospital of Lianyungang
Transfusion-dependent Non-severe Aplastic Anemia
1 trial -
MTBF regimen
The First People's Hospital of Lianyungang
Relapse Leukemia
1 trial -
Mailed nicotine replacement therapy (NRT)
The University of Hong Kong
Smoking Cessation
1 trial -
Maternal Nutritional Supplement
Abbott Australasia Pty Ltd
Breast Feeding
1 trial -
Medical Management
The First People's Hospital of Lianyungang
Acute Ischemic Stroke
1 trial -
Medical Treatment
The First People's Hospital of Lianyungang
Basilar Artery Occlusion
1 trial -
Medical therapy
The First People's Hospital of Lianyungang
Aortic Valve Disease
1 trial -
Medical treatment alone
Hospital Authority, Hong Kong
Intracranial Arteriosclerosis
1 trial -
Medium-quantity lipid-based nutrient supplement (MQ-LNS)
United Therapeutics Europe Ltd
Undernutrition
1 trial -
Melatonin supplement intervention
United Therapeutics Europe Ltd
Physical Exercise
1 trial -
Metformin
The First People's Hospital of Lianyungang
Endometrial Cancer
1 trial -
Metformin hydrochloride sustained release tablets
The First People's Hospital of Lianyungang
Osteoarthritis
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources